Search Results for citation:"90 FR 12294"

Found 2 results

Search Results: citation:"90 FR 12294"

💰 Only
Oldest Newest
  • 2025-04137 — Notice of Public Meeting of the District of Columbia Advisory Committee to the U.S. Commission on Civil Rights
    Type:Notice
    Citation:90 FR 12294
    Reading Time:about 2 minutes

    The U.S. Commission on Civil Rights will hold a virtual public meeting for the District of Columbia Advisory Committee on April 3, 2025, from 12 p.m.-1 p.m. Eastern Time. The meeting will focus on discussing the accessibility and provision of special education for students with disabilities in DC public schools. Members of the public can attend and are allowed to make oral statements during the open comment period. Additional accommodations can be requested by contacting the Commission 10 business days before the meeting.

    Simple Explanation

    The government is having an online meeting to talk about how kids with disabilities are helped in schools in Washington, D.C. People can join the meeting, ask questions, and if they need extra help, they should ask ahead of time.

  • 2025-04257 — Foreign-Trade Zone (FTZ) 43, Notification of Proposed Production Activity; Pfizer, Inc.; (Pharmaceutical Intermediate Product); Kalamazoo, Michigan
    Type:Notice
    Citation:90 FR 12294
    Reading Time:about a minute or two

    Pfizer, Inc. has submitted a proposal to the Foreign-Trade Zones Board to allow specific production activities at its Kalamazoo, Michigan facilities within Subzone 43E. This proposal covers the production of a pharmaceutical intermediate product called phthalimido lactol, using a foreign-supplied material, 3 phthalimidopropionaldehyde (3-PPA), both with a duty rate of 6.5%. The foreign component may be subject to certain duties based on its country of origin and must be admitted to the zone in a specific status under U.S. trade regulations. Public comments are invited until April 28, 2025, and further details can be found on the Board's website or by contacting Diane Finver.

    Simple Explanation

    Pfizer wants to make a special ingredient for medicine at a factory in Michigan, and they are asking for permission to do it in a way that helps with taxes on the materials they use. People can say if they think this is a good idea until the end of April.